Literature DB >> 14748563

Increased expression of erythropoietin receptor on blood vessels in the human epileptogenic hippocampus with sclerosis.

Tore Eid1, Michael L Brines, Anthony Cerami, Dennis D Spencer, Jung H Kim, Jeffrey S Schweitzer, Ole P Ottersen, Nihal C de Lanerolle.   

Abstract

Microvascular (capillary) proliferation is a readily observed, but largely ignored phenomenon of the mesial temporal lobe epilepsy (MTLE) hippocampus. Here, we report that the proliferated capillaries in surgically resected MTLE hippocampi were strongly immunoreactive for erythropoietin receptor (EPO-r). Further, we found that these capillaries were most prominent in areas of the MTLE hippocampus with extensive neuronal loss and gliosis, i.e. the CA3, CA1, and dentate hilus. High-resolution immunogold electron microscopy revealed that the capillary EPO-r was localized to the luminal and abluminal plasma membrane of endothelial cells, to endosome-like structures of these cells, and to pericapillary astrocytic end-feet. Previous studies have shown that systemically administered EPO appears in the cerebrospinal fluid in experimental animals, and the present results are consistent with the idea that EPO enters the brain via receptor-mediated endocytosis. The enrichment of EPO-r shown here suggests a highly efficient uptake of plasma EPO into the MTLE hippocampus and a possible role for this cytokine in epileptogenesis. Moreover, the presence of EPO-r in the MTLE hippocampus may provide a new vehicle for highly efficient delivery of hitherto impermeable drugs into the epileptic brain.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14748563     DOI: 10.1093/jnen/63.1.73

Source DB:  PubMed          Journal:  J Neuropathol Exp Neurol        ISSN: 0022-3069            Impact factor:   3.685


  15 in total

1.  Erythropoietin: still on the neuroprotection road.

Authors:  Nelvys Subirós; Diana García Del Barco; Rosa M Coro-Antich
Journal:  Ther Adv Neurol Disord       Date:  2012-05       Impact factor: 6.570

2.  Recombinant Human Erythropoietin: Novel Strategies for Neuroprotective/Neuro-regenerative Treatment of Multiple Sclerosis.

Authors:  Claudia Bartels; Kira Späte; Henning Krampe; Hannelore Ehrenreich
Journal:  Ther Adv Neurol Disord       Date:  2008-11       Impact factor: 6.570

Review 3.  Localization of brain endothelial luminal and abluminal transporters with immunogold electron microscopy.

Authors:  Eain M Cornford; Shigeyo Hyman
Journal:  NeuroRx       Date:  2005-01

Review 4.  Diverse roles of the vasculature within the neural stem cell niche.

Authors:  Joshua S Goldberg; Karen K Hirschi
Journal:  Regen Med       Date:  2009-11       Impact factor: 3.806

Review 5.  The Potential Roles of Aquaporin 4 in Alzheimer's Disease.

Authors:  Yu-Long Lan; Jie Zhao; Tonghui Ma; Shao Li
Journal:  Mol Neurobiol       Date:  2015-10-03       Impact factor: 5.590

Review 6.  The potential of antiseizure drugs and agents that act on novel molecular targets as antiepileptogenic treatments.

Authors:  Rafal M Kaminski; Michael A Rogawski; Henrik Klitgaard
Journal:  Neurotherapeutics       Date:  2014-04       Impact factor: 7.620

Review 7.  Regulation of astrocyte glutamine synthetase in epilepsy.

Authors:  Tore Eid; Nathan Tu; Tih-Shih W Lee; James C K Lai
Journal:  Neurochem Int       Date:  2013-06-18       Impact factor: 3.921

Review 8.  Astrocytes and epilepsy.

Authors:  Nihal C de Lanerolle; Tih-Shih Lee; Dennis D Spencer
Journal:  Neurotherapeutics       Date:  2010-10       Impact factor: 7.620

9.  Optimal neuroprotection by erythropoietin requires elevated expression of its receptor in neurons.

Authors:  Pascal E Sanchez; Raafat P Fares; Jean-Jacques Risso; Chantal Bonnet; Sandrine Bouvard; Marion Le-Cavorsin; Béatrice Georges; Colette Moulin; Amor Belmeguenai; Jacques Bodennec; Anne Morales; Jean-Marc Pequignot; Etienne-Emile Baulieu; Robert A Levine; Laurent Bezin
Journal:  Proc Natl Acad Sci U S A       Date:  2009-06-03       Impact factor: 11.205

10.  Erythropoietin and its receptors in the brainstem of adults with fatal falciparum malaria.

Authors:  Isabelle M Medana; Nicholas P J Day; Tran Tinh Hien; Nicholas J White; Gareth D H Turner
Journal:  Malar J       Date:  2009-11-22       Impact factor: 2.979

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.